{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:51Z","timestamp":1792788591328,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI124284"],"award-info":[{"award-number":["U01AI124284"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Human Immunology Project Consortium","award":["U19AI118608"],"award-info":[{"award-number":["U19AI118608"]}]},{"DOI":"10.13039\/100005295","name":"American Academy of Pediatrics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danish National Research Foundation","doi-asserted-by":"publisher","award":["DNRF108"],"award-info":[{"award-number":["DNRF108"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Organization for Scientific Research","id":[{"id":"https:\/\/ror.org\/04jsz6e67","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MC_UP_A900\/1122"],"award-info":[{"award-number":["MC_UP_A900\/1122"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/K011944\/1"],"award-info":[{"award-number":["MR\/K011944\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.11.060","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T09:03:16Z","timestamp":1580202196000},"page":"2229-2240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Licensed Bacille Calmette-Gu\u00e9rin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation"],"prefix":"10.1016","volume":"38","author":[{"given":"Asimenia","family":"Angelidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Giulia","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joann","family":"Diray-Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-3810","authenticated-orcid":false,"given":"Christine S.","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Shann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Prasad","family":"Potluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guzman","family":"Sanchez-Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Ozonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Dani\u00ebl","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.060_b0005","unstructured":"UNICEF. BCG vaccine: current supply & demand outlook; 2015."},{"key":"10.1016\/j.vaccine.2019.11.060_b0010","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2019.11.060_b0015","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S1473-3099(18)30157-9","article-title":"Tuberculosis susceptibility and protection in children","volume":"19","author":"Basu Roy","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0020","doi-asserted-by":"crossref","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.11.060_b0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial","volume":"65","author":"Biering-Sorensen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0030","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2016.07.022","article-title":"Different effects of BCG strains \u2013 A natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau","volume":"34","author":"Frankel","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.060_b0035","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1080\/21645515.2017.1421879","article-title":"Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study","volume":"14","author":"Funch","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.11.060_b0040","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2019.11.060_b0045","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1038\/ncomms11290","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.11.060_b0050","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.vaccine.2012.01.053","article-title":"The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda","volume":"30","author":"Anderson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.060_b0055","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/cid\/civ452","article-title":"Development of BCG Scar and Subsequent Morbidity and Mortality in Rural Guinea-Bissau","volume":"61","author":"Storgaard","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0060","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.vaccine.2015.02.056","article-title":"Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial","volume":"33","author":"Biering-Sorensen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.060_b0065","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Guerin (BCG) vaccine: a global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.060_b0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/INF.0000000000002230","article-title":"BCG vaccination and all-cause neonatal mortality","volume":"38","author":"Curtis","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.11.060_b0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/21645515.2017.1382788","article-title":"The patterns of in vitro cell-death and inflammatory cytokines induced by distinct BCG vaccine strains are differentially induced in human mononuclear cells","volume":"14","author":"Ponte","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.11.060_b0085","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0264-410X(98)00277-1","article-title":"A historical and molecular phylogeny of BCG strains","volume":"17","author":"Behr","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.060_b0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00006454-199402000-00007","article-title":"Osteitis after newborn vaccination with three different Bacillus Calmette-Guerin vaccines: twenty-nine years of experience","volume":"13","author":"Kroger","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.11.060_b0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/499825","article-title":"The effect of bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants","volume":"193","author":"Davids","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0100","first-page":"125","article-title":"Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains","volume":"134C","author":"Gheorghiu","year":"1983","journal-title":"Ann Immunol (Paris)"},{"key":"10.1016\/j.vaccine.2019.11.060_b0105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/cid\/civ454","article-title":"Editorial commentary: different strains of bacillus calmette-guerin vaccine have very different effects on tuberculosis and on unrelated infections","volume":"61","author":"Shann","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/rccm.201104-0714OC","article-title":"The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial","volume":"185","author":"Ritz","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2019.11.060_b0115","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41590-018-0068-4","article-title":"Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses","volume":"19","author":"Ugolini","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1279771","article-title":"Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70","volume":"13","author":"Dai","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.11.060_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2018.00029","article-title":"Adjuvant Effect of Bacille Calmette-Guerin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn","volume":"9","author":"Scheid","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1099\/mic.0.28604-0","article-title":"Biofilm formation by mycoplasma species and its role in environmental persistence and survival","volume":"152","author":"McAuliffe","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2019.11.060_b0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature04517","article-title":"Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin\/Nalp3","volume":"440","author":"Kanneganti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.11.060_b0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10072","article-title":"Detection of prokaryotic mRNA signifies microbial viability and promotes immunity","volume":"474","author":"Sander","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.11.060_b0145","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.vaccine.2014.09.065","article-title":"The establishment of sub-strain specific WHO Reference Reagents for BCG vaccine","volume":"32","author":"Dagg","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.060_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(83)90044-2","article-title":"Changes in BCG strains","volume":"64","author":"Osborn","year":"1983","journal-title":"Tubercle"},{"key":"10.1016\/j.vaccine.2019.11.060_b0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.vetmic.2011.10.016","article-title":"Primary isolation of Mycobacterium bovis from bovine tissues: conditions for maximising the number of positive cultures","volume":"156","author":"Corner","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tube.2018.06.001","article-title":"Can colony-forming unit testing be used to extend the shelf life of BCG vaccines?","volume":"111","author":"Messina","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2019.11.060_b0165","first-page":"251","article-title":"Stabilisation of BCG vaccines","volume":"87","author":"Gheorghiu","year":"1996","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2019.11.060_b0170","doi-asserted-by":"crossref","first-page":"e32567","DOI":"10.1371\/journal.pone.0032567","article-title":"Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan","volume":"7","author":"Favorov","year":"2012","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.060_b0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/INF.0000000000002198","article-title":"Two randomized trials of the effect of BCG-Russia alone or with oral polio vaccine on neonatal mortality in infants weighing <2000 G in India","volume":"38","author":"Jayaraman","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.11.060_b0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7883\/yoken.JJID.2007.331","article-title":"Historical review of BCG vaccine in Japan","volume":"60","author":"Yamamoto","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0185","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.163.7.3920","article-title":"Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis","volume":"163","author":"Means","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0190","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.4049\/jimmunol.158.4.1742","article-title":"Differential responses to challenge with live and dead Mycobacterium bovis Bacillus Calmette-Guerin","volume":"158","author":"Chambers","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2567.1996.512590.x","article-title":"Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro","volume":"87","author":"Turner","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.11.060_b0200","series-title":"Hematology: Diagnosis and Treatment","first-page":"311","author":"Hoffman","year":"2013"},{"key":"10.1016\/j.vaccine.2019.11.060_b0205","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.168.6.2820","article-title":"Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells","volume":"168","author":"White","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaci.2009.03.040","article-title":"Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations","volume":"124","author":"van den Biggelaar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0215","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.3389\/fimmu.2018.02634","article-title":"Microphysiologic Human Tissue Constructs Reproduce Autologous Age-Specific BCG and HBV Primary Immunization in vitro","volume":"9","author":"Sanchez-Schmitz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0220","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0225","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1128\/IAI.00244-07","article-title":"Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin","volume":"75","author":"Wu","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.11.060_b0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imr.12617","article-title":"The role of the interleukin-1 family in trained immunity","volume":"281","author":"Moorlag","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2019.11.060_b0235","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.060_b0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1006\/cyto.1997.0242","article-title":"Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan","volume":"9","author":"Vouret-Craviari","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2019.11.060_b0245","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1038\/s41598-018-26984-3","article-title":"GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection","volume":"8","author":"Benmerzoug","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.11.060_b0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-2478(90)90049-V","article-title":"Granulocyte-macrophage colony-stimulating factor restricts growth of tubercle bacilli in human macrophages","volume":"24","author":"Denis","year":"1990","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2019.11.060_b0255","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2016.12.985","article-title":"Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses","volume":"140","author":"Dowling","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.11.060_b0260","article-title":"Maternal Priming: Bacillus Calmette-Gu\u00e9rin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine Scar.","author":"Berendsen","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2019.11.060_bib261","article-title":"Early vaccination with BCG-Denmark or BCG-Japan versus BCG-Russia to healthy newborns in Guinea-Bissau: A randomized controlled trial","author":"Schaltz-Buchholzer","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:14Z","timestamp":1759401614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316147"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Licensed Bacille Calmette-Gu\u00e9rin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}